QAdvis is now officially part of Aurevia, following our company’s integration into Aurevia. As Aurevia, we provide QARA expertise covering the entire lifecycle of medical devices and in vitro diagnostics, from early development to post-market phases globally. Additionally, Aurevia operates as a full-service contract research organization (CRO) supporting pharmaceuticals, medical devices, and in vitro diagnostics, and also External Quality Assessment (EQA) services. We understand the challenges of navigating the complex landscape of medical and in vitro diagnostic device development and market surveillance. Transforming a concept into a market-ready medical device requires a strategic and systematic approach. With a proven track record of successful projects, we are ready to share our insights and support you throughout the development, market launch and the post market surveillance of your medical device. Whether you are a startup or an established organization, our expertise spans across various medical devices and device classes. We collaborate closely with you and help you to turn your vision into reality, mitigating risks and optimizing the timelines. Feel free to contact us at +46 (0)8 621 01 05, info.qadvis@aurevia.com or just drop us a message here on LinkedIn. We will get back to you shortly.
Looking for a particular QAdvis employee's phone or email?
The QAdvis annual revenue was $3 million in 2026.
26 people are employed at QAdvis.
QAdvis is based in Kista, Stockholm.
The NAICS codes for QAdvis are [54171, 541, 5417, 54, 541713].
The SIC codes for QAdvis are [873, 87].